Product
Meningococcal group A, C, W-135, and Y conjugate vaccine
Aliases
Nimenrix®
2 clinical trials
3 indications
Indication
meningococcal immunizationIndication
Healthy Control ParticipantsIndication
Meningococcal InfectionsClinical trial
Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix®, and When Administered Alone or Concomitantly With 9vHPV and Tdap-IPV Vaccines in Healthy AdolescentsStatus: Completed, Estimated PCD: 2022-05-11
Clinical trial
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in EuropeStatus: Completed, Estimated PCD: 2023-05-17